Search research articles
Contact Us
Filters
Showing results (121-130 of 171) with videos related to
Page
of 18
Sort By:
Vaccine
|
June 8, 2001
Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particles
T J Palker, J M Monteiro, M M Martin, et al.
Protein Expression and Purification
|
June 1, 1993
Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiae
E D Lehman, J G Joyce, F J Bailey, et al.
The Journal of Biological Chemistry
|
February 20, 1999
The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes
J G Joyce, J S Tung, C T Przysiecki, et al.
Protein Expression and Purification
|
October 26, 2001
An enhanced and scalable process for the purification of SIV Gag-specific MHC tetramer
K M Grimm, W L Trigona, G J Heidecker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2021
The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat
David C Montefiori, Maria V Filsinger Interrante, Benjamin N Bell, et al.
AIDS Research and Human Retroviruses
|
December 24, 2008
Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41
Renee Hrin, Donna L Montgomery, Fubao Wang, et al.
Vaccine
|
January 17, 2009
Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys
Tong-Ming Fu, Karen M Grimm, Michael P Citron, et al.
Virology
|
June 1, 1995
Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae
K J Hofmann, J C Cook, J G Joyce, et al.
Human Vaccines & Immunotherapeutics
|
December 20, 2012
Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197
Ivette Caro-Aguilar, Elizabeth Ottinger, Robert W Hepler, et al.
Journal of Chromatography
|
February 14, 1992
Large-scale purification and characterization of recombinant tick anticoagulant peptide
E D Lehman, T F Schaefer, C T Przysiecki, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 171) with videos related to
Sort By:
Page
of 18
Vaccine
|
June 8, 2001
Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particles
T J Palker, J M Monteiro, M M Martin, et al.
Protein Expression and Purification
|
June 1, 1993
Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiae
E D Lehman, J G Joyce, F J Bailey, et al.
The Journal of Biological Chemistry
|
February 20, 1999
The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes
J G Joyce, J S Tung, C T Przysiecki, et al.
Protein Expression and Purification
|
October 26, 2001
An enhanced and scalable process for the purification of SIV Gag-specific MHC tetramer
K M Grimm, W L Trigona, G J Heidecker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2021
The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat
David C Montefiori, Maria V Filsinger Interrante, Benjamin N Bell, et al.
AIDS Research and Human Retroviruses
|
December 24, 2008
Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41
Renee Hrin, Donna L Montgomery, Fubao Wang, et al.
Vaccine
|
January 17, 2009
Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys
Tong-Ming Fu, Karen M Grimm, Michael P Citron, et al.
Virology
|
June 1, 1995
Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae
K J Hofmann, J C Cook, J G Joyce, et al.
Human Vaccines & Immunotherapeutics
|
December 20, 2012
Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197
Ivette Caro-Aguilar, Elizabeth Ottinger, Robert W Hepler, et al.
Journal of Chromatography
|
February 14, 1992
Large-scale purification and characterization of recombinant tick anticoagulant peptide
E D Lehman, T F Schaefer, C T Przysiecki, et al.
Page
of 18